Ebstein’s Anomaly Lawyer & Lawsuit

The rare congenital birth defect referred to as Ebstein’s anomaly is characterized by a malfunctioning tricuspid valve. The defective valve allows blood to leak back through where it originally came from. The result of the malfunctioning valve inevitably makes the heart work less efficiently and may lead to severe and potentially life threatening side…

Read More

FDA: Link Between SSRI Antidepressants and Birth Defects Remains Ambiguous

According to a Safety Announcement issued by the U.S. Food and Drug Administration (FDA), recent studies have added significant weight to the link between a distinct group of antidepressants and a rare heart and lung condition known as persistent pulmonary hypertension of the newborn (PPHN). Subsequently, pregnant women who receive selective serotonin reuptake inhibitor…

Read More

Spina Bifida Lawyer & Lawsuit

Spina bifida is a congenital birth defect characterized by an underdeveloped neural tube. The neural tube is an embryonic structure that eventually develops into the baby’s brain, spinal cord, and their surrounding tissues. As a result, the spinal cord and backbone will develop severe, life-threatening defects. In this article we will discuss the signs…

Read More

Zoloft® Lawyer & Lawsuit

Zoloft (generic: sertraline) is a unique antidepressant medication that is used to treat depression, obsessive-compulsive disorder, panic disorder, anxiety disorders, post-traumatic stress disorder (PTSD), and premenstrual dysphoric disorder (PMDD). However, recent studies suggest that Zoloft may be responsible for the development of catastrophic birth defects. Subsequently, pregnant women who receive Zoloft treatment may significantly…

Read More

Humira® Lawyer & Lawsuit

Humira (adalimumab) is an injectable prescription medicine intended to assist in the treatment of several autoimmune disorders. However, the use of Humira on such disorders has become synonymous with catastrophic complications. Patients who receive Humira treatment may significantly increase their risk of developing extensive nerve damage, opportunistic infections and severe, life-threatening forms of cancer….

Read More

Multaq Label Change Reveals Increased Cardiovascular Risk

New evidence lends weight to the long-suspected link between Multaq, a popular heart medication, and adverse cardiovascular events. Subsequently, the U.S. Food and Drug Administration (FDA) acknowledged that significant changes have been made to the labels of Multaq products. According to two clinical trials, Multaq may be responsible for several severe cardiovascular events. Patients…

Read More

Lack of Federal Regulation May Result in the Release of Dangerous Cosmetics

Brazilian Blowout, a popular hair straightening solution, has recently become a subject of increasing criticism. The inclusion of formaldehyde, in particular, has been linked to adverse health complications in those exposed to it. Otherwise known as a carcinogen, formaldehyde has been associated with the development of nose and throat cancers, leukemia, respiratory problems and…

Read More

Popular Energy Drink Becomes Focus in FDA Investigation

Increasing concern continues to reign over the entire energy drink industry. Subsequently, understudied and unregulated ingredients contained within the popular energy drinks of today have been associated with adverse health events in populations that consume them on a regular basis. Of significant concern, however, are reports issued by the U.S. Food and Drug Administration…

Read More